Aim Prolactinoma, a prolactin (PRL) secreting functioning pituitary tumor, is the most
common of all pituitary adenomas (PA) accounting for 40-60% and dopamine agonists (DA) …

Background: Prolactinomas are the most common type of functional pituitary tumours. The
objective of this study was to determine demographic profile of patients with prolactinomas …

A prolactin-secreting pituitary tumour is the most frequent cause of hyperprolactinaemia that
commonly occurs in clinical practice. Prolactinomas occur more frequently in women than in …

Simple Summary This review updates recent advances in the pathogenesis, diagnosis, and
therapy of prolactinoma. Prolactinomas, comprising 30–50% of all pituitary neuroendocrine …

Objectives: Identify the common presentations of prolactinomas. Outline the evaluation of
prolactinomas. Review the management of prolactinomas. Explain the role of collaboration …

Prolactinomas (PRLomas) constitute approximately half of all pituitary adenomas and
approximately one-fifth of them are diagnosed in males. The clinical presentation of …

Background Prolactinomas are the commonest functional tumors of the pituitary gland.
There are still controversies regarding medical therapy in specific clinical situations. Patients …

Prolactinoma is the most frequent pituitary adenoma type, accounting for 40–66% in
epidemiological studies [1]. The estimated prevalence in various populations ranges from …

Prolactinoma usually occurs a small intrasellar tumor in women or as a large tumor in men.
To determine whether the predominance of macroprolactinomas in men is due to a delay in …

Objective To review our experience with long-term cabergoline and bromocriptine therapy in
the treatment of giant prolactinomas. Methods Patients with giant prolactinomas diagnosed …